Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Microbot Medical Inc. (MBOT)
|
Add to portfolio |
|
|
|
| Price: |
$7.93
| | Metrics |
| OS: |
11.7
|
M
| |
|
|
| Market cap: |
$92.8
|
M
| |
|
|
|
Net cash:
|
$9.92
|
M
| |
$0.85
|
per share
|
|
EV:
|
$82.9
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | -6.6 | -5.8 | -1.3 | 0.0 | 0.0 | 10.5 | 0.0 | 0.0 |
| Revenue growth | 14.5% | 341.8% | | | -100.0% | | | |
| Cost of goods sold | 2.1 | 1.9 | 1.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | -8.7 | -7.7 | -2.6 | 0.0 | 0.0 | 10.5 | 0.0 | 0.0 |
| Gross margin | 131.2% | 133.0% | 200.0% | | | 100.0% | | |
| Selling, general and administrative | | | | | | | | |
| Research and development | 7.7 | 6.2 | 3.4 | 3.4 | 3.0 | 1.1 | 0.9 | 0.8 |
| General and administrative | 5.5 | 5.2 | 5.7 | 5.7 | 4.2 | 4.2 | 8.7 | 0.1 |
| EBIT | -13.3 | -11.4 | -9.1 | -9.1 | -7.2 | 5.3 | -9.6 | -0.9 |
| EBIT margin | 200.3% | 196.2% | 693.8% | | | 50.0% | | |
| Pre-tax income | -13.2 | -11.3 | -9.2 | 0.0 | 0.0 | 7.6 | -9.7 | -0.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | | | 0.0% | 0.0% | 0.0% |
| Net income | -13.2 | -11.3 | -9.2 | 0.0 | 0.0 | 7.6 | -9.7 | -0.9 |
| Net margin | 198.6% | 195.5% | 699.9% | | | 72.0% | | |
| |
| Diluted EPS | ($1.81) | ($1.59) | ($1.29) | $0.00 | $0.00 | $3.48 | ($0.68) | ($0.07) |
| Shares outstanding (diluted) | 7.3 | 7.1 | 7.1 | 7,117.7 | 4,267.2 | 2.2 | 14.3 | 13.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|